首页> 外国专利> Encapsulation and deaggregation of polyene antibiotics using poly(ethylene glycol)-phospholipid micelles

Encapsulation and deaggregation of polyene antibiotics using poly(ethylene glycol)-phospholipid micelles

机译:使用聚(乙二醇)-磷脂微团的多烯抗生素的包封和解聚

摘要

AmphotericinB (or other hydrophobic compound) is encapsulated in a deaggregated form in micelles of monomethoxy poly(ethylene glycol)-phospholipid (as specifically exemplified, the phospholipid is 1,2 di-stearoyl-sn-glycero-3-phosphatidyl ethanolamine) formed by solvent evaporation. Advantageously, the hydration of the dried drug-polymer film is carried at between about 25° C., and about 80° C. The micelles can be reconstituted with the Amphotericin B (or other hydrophobic compound) in a deaggregated state and safely used in therapy for fungal infections of humans or animals, especially for systemic fungal infections, or other desired application. The polyene micellar formulations described herein are reduced in toxicity as compared with those polyene formulations in which there is significant occurrence of aggregated polyenes.
机译:两性霉素B(或其他疏水性化合物)以解聚形式封装在单甲氧基聚(乙二醇)-磷脂(具体示例为磷脂为1,2-二硬脂酰基-sn-甘油-3-磷脂酰乙醇胺)的胶束中溶剂蒸发。有利地,干燥的药物-聚合物膜的水合作用在约25°至约25°之间。约80℃。 C.胶束可以用两性霉素B(或其他疏水性化合物)以解聚状态重构,并可以安全地用于治疗人或动物的真菌感染,尤其是全身性真菌感染或其他所需的应用。与其中显着发生聚集多烯的那些多烯制剂相比,本文所述的多烯胶束制剂的毒性降低。

著录项

  • 公开/公告号US2004116360A1

    专利类型

  • 公开/公告日2004-06-17

    原文格式PDF

  • 申请/专利权人 KWON GLEN S.;

    申请/专利号US20030687558

  • 发明设计人 GLEN S. KWON;

    申请日2003-10-15

  • 分类号A61K31/7048;A61K9/127;

  • 国家 US

  • 入库时间 2022-08-21 23:20:47

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号